Edge Medical-B (02675) has announced a strategic investment in Yuanhao Motion (Beijing) Technology Co., Ltd., an independent third party, as disclosed by the company's board of directors.
This investment is set to strengthen Edge Medical-B's capabilities in the realm of "AI plus surgical robotics" for intelligent surgery. It aims to lay a strategic foundation for the development of embodied intelligent medical robots. Yuanhao Motion is an AI company specializing in the research and development of a fifth-generation, multi-modal 4D world model foundation, founded by a top-tier team with Tsinghua University backgrounds. The company focuses on building a unified model system for dynamic world reconstruction, generation, simulation, and agent training, with applications in embodied intelligence, autonomous surgery, gaming, film, and autonomous driving. Its goal is to create a universal world model base for the physical AI era.
Edge Medical-B primarily engages in the design, development, and manufacturing of minimally invasive surgical robots and instruments, providing innovative solutions for surgical procedures. This investment will help the company expand into the application of "AI plus surgical robots" in embodied intelligence, establish a collaborative foundation with relevant technical teams, and explore the potential to extend from single surgical robot equipment to an embodied intelligent surgical robot platform. The board believes this investment aligns with the overall interests of the company and its shareholders.
Comments